Document is current
Any future updates will be listed below
-
Authors
Löfberg, Andreas
Harp, Nicholas
Perini, Irene https://orcid.org/0000-0002-5972-0913
Kämpe, Robin https://orcid.org/0000-0002-1107-5644
Karlsson, Hanna
Pietrzak, Michal
Kober, Hedy https://orcid.org/0000-0001-9893-1046
Heilig, Markus
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (R01AA029137)
Vetenskapsrådet (2013-07434)
Knut och Alice Wallenbergs Stiftelse (Clinical Scholar Grant)
EC | Horizon 2020 Framework Programme (668863-SyBil-AA)
- License Information
-
More Information
Article History
Received: 26 September 2025
Revised: 29 January 2026
Accepted: 3 February 2026
First Online: 25 February 2026
Competing interests
: MH has received speaker’s fees, research funding and/ or scientific advisory board compensation from Lundbeck, Aelis Farma, Indivior, Brainsway Technologies, Accord Pharma, Nordic Drugs, Idorsia and Janssen Pharmaceuticals; and is a Senior Editor at Neuropsychopharmacology. The remaining authors have nothing to disclose.
